Global Gene Therapies for Cancer Treatment Market Growth (Status and Outlook) 2025-2031

According to this study, the global Gene Therapies for Cancer Treatment market size will reach US$ million by 2031.

In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient"s cells as a drug to treat disease.

United States market for Gene Therapies for Cancer Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Gene Therapies for Cancer Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Gene Therapies for Cancer Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Gene Therapies for Cancer Treatment players cover Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Gene Therapies for Cancer Treatment Industry Forecast” looks at past sales and reviews total world Gene Therapies for Cancer Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapies for Cancer Treatment sales for 2025 through 2031. With Gene Therapies for Cancer Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapies for Cancer Treatment industry.

This Insight Report provides a comprehensive analysis of the global Gene Therapies for Cancer Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapies for Cancer Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapies for Cancer Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapies for Cancer Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapies for Cancer Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapies for Cancer Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)

Segmentation by Application:
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takara Bio
Tocagen
VBL Therapeutics
Cold Genesys
Genprex
Momotaro-Gene
MultiVir
SynerGene Therapeutics
Ziopharm Oncology
Anchiano Therapeutics
Celgene
Celsion
Bluebird Bio

Please note: The report will take approximately 2 business days to prepare and deliver. Show more